"Serum Amyloid A Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.
| Descriptor ID |
D000685
|
| MeSH Number(s) |
D12.776.049.407.750 D12.776.124.050.725
|
| Concept/Terms |
Serum Amyloid A Protein- Serum Amyloid A Protein
- Amyloid A Protein-Related Serum Component
- Amyloid A Protein Related Serum Component
- Amyloid Protein AA Precursor
- Serum Amyloid Protein A
- Amyloid Serum Protein SAA
- Amyloid-Related Serum Protein (SAA)
- Serum A Related Protein
- Serum Amyloid A
- Amyloid A Precursor
- Amyloid Protein SAA
|
Below are MeSH descriptors whose meaning is more general than "Serum Amyloid A Protein".
Below are MeSH descriptors whose meaning is more specific than "Serum Amyloid A Protein".
This graph shows the total number of publications written about "Serum Amyloid A Protein" by people in this website by year, and whether "Serum Amyloid A Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serum Amyloid A Protein" by people in Profiles.
-
Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases. Am J Kidney Dis. 2018 10; 72(4):612-616.
-
A Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: The Optimizing Antibiotic Strategies in Sepsis (OASIS) Study. J Pediatric Infect Dis Soc. 2017 Jun 01; 6(2):134-141.
-
Serum amyloid A and atherosclerosis. Curr Opin Lipidol. 2016 10; 27(5):531-5.
-
Serum amyloid A regulates monopoiesis in hyperlipidemic Ldlr(-/-) mice. FEBS Lett. 2016 08; 590(16):2650-60.
-
Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice. J Am Heart Assoc. 2015 Jul 17; 4(7).
-
Serum amyloid A proteins take retinol for a ride. Trends Immunol. 2014 Nov; 35(11):505-6.
-
Systemic inflammation, intraventricular hemorrhage, and white matter injury. J Child Neurol. 2013 Dec; 28(12):1637-45.
-
Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation. J Biol Chem. 2012 Jul 20; 287(30):25669-77.
-
4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J. 2011 Jan; 25(1):290-300.
-
Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch. FASEB J. 2009 Oct; 23(10):3436-48.